TCR signalling in naïve CD4+ T cells, T cell activation, FoxO family signalling and Fc-epsilon receptor I signalling in mast cells were among the most statistically significant common pathways between MS susceptibility and severity. This evidence concerns the gene CD4 and myeloid sarcoma.